1 序文
2 範囲と方法論
2.1 調査の目的
2.2 利害関係者
2.3 データソース
2.3.1 一次ソース
2.3.2 二次ソース
2.4 市場推定
2.4.1 ボトムアップアプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法論
3 エグゼクティブサマリー
4 はじめに
4.1 概要
4.2 主な業界動向
5 世界の医療用融解システム市場
5.1 市場概要
5.2 市場実績
5.3 COVID-19 の影響
5.4 市場予測
6 製品タイプ別市場内訳
6.1 手動
6.1.1 市場動向
6.1.2 市場予測
6.2 自動
6.2.1 市場動向
6.2.2 市場予測
7 サンプルタイプ別市場内訳
7.1 血液
7.1.1 市場動向
7.1.2 主要セグメント
7.1.2.1 血漿
7.1.2.2 幹細胞
7.1.2.3 全血
7.1.2.4 血小板
7.1.3 市場予測
7.2 胚
7.2.1 市場動向
7.2.2 市場予測
7.3 卵子
7.3.1 市場動向
7.3.2 市場予測
7.4 精液
7.4.1 市場動向
7.4.2 市場予測
8 エンドユーザー別市場内訳
8.1 血液銀行
8.1.1 市場動向
8.1.2 市場予測
8.2 病院
8.2.1 市場動向
8.2.2 市場予測
8.3 組織銀行
8.3.1 市場動向
8.3.2 市場予測
8.4 製薬会社およびバイオテクノロジー企業
8.4.1 市場動向
8.4.2 市場予測
8.5 その他
8.5.1 市場動向
8.5.2 市場予測
9 地域別市場内訳
9.1 北米
9.1.1 米国
9.1.1.1 市場動向
9.1.1.2 市場予測
9.1.2 カナダ
9.1.2.1 市場動向
9.1.2.2 市場予測
9.2 アジア太平洋地域
9.2.1 中国
9.2.1.1 市場動向
9.2.1.2 市場予測
9.2.2 日本
9.2.2.1 市場動向
9.2.2.2 市場予測
9.2.3 インド
9.2.3.1 市場動向
9.2.3.2 市場予測
9.2.4 韓国
9.2.4.1 市場動向
9.2.4.2 市場予測
9.2.5 オーストラリア
9.2.5.1 市場動向
9.2.5.2 市場予測
9.2.6 インドネシア
9.2.6.1 市場動向
9.2.6.2 市場予測
9.2.7 その他
9.2.7.1 市場動向
9.2.7.2 市場予測
9.3 ヨーロッパ
9.3.1 ドイツ
9.3.1.1 市場動向
9.3.1.2 市場予測
9.3.2 フランス
9.3.2.1 市場動向
9.3.2.2 市場予測
9.3.3 英国
9.3.3.1 市場動向
9.3.3.2 市場予測
9.3.4 イタリア
9.3.4.1 市場動向
9.3.4.2 市場予測
9.3.5 スペイン
9.3.5.1 市場動向
9.3.5.2 市場予測
9.3.6 ロシア
9.3.6.1 市場動向
9.3.6.2 市場予測
9.3.7 その他
9.3.7.1 市場動向
9.3.7.2 市場予測
9.4 ラテンアメリカ
9.4.1 ブラジル
9.4.1.1 市場動向
9.4.1.2 市場予測
9.4.2 メキシコ
9.4.2.1 市場動向
9.4.2.2 市場予測
9.4.3 その他
9.4.3.1 市場動向
9.4.3.2 市場予測
9.5 中東およびアフリカ
9.5.1 市場動向
9.5.2 国別の市場内訳
9.5.3 市場予測
10 SWOT分析
10.1 概要
10.2 強み
10.3 弱み
10.4 機会
10.5 脅威
11 バリューチェーン分析
12 ポーターのファイブフォース分析
12.1 概要
12.2 買い手の交渉力
12.3 売り手の交渉力
12.4 競争の度合い
12.5 新規参入の脅威
12.6 代替品の脅威
13 価格分析
14 競合状況
14.1 市場構造
14.2 主要企業
14.3 主要企業のプロフィール
Barkey GmbH & Co. KG
Biolife Solutions Inc
Boekel Scientific
Cardinal Health Inc
General Electric Company
Helmer Scientific Inc
Hospicare Systems
labcold Limited
MMS Medical and Laboratory Supplies
Sarstedt AG & Co. KG
Sartorius AG
Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc.
A medical thawing system is used in healthcare facilities to thaw frozen biological specimens such as blood products, vaccines, and tissue samples safely and quickly. It employs a controlled process of heating and agitating the frozen specimen in a water bath, allowing it to thaw evenly without causing any damage to the sample. In addition to this, they help minimize the risk of contamination, ensure accurate and reliable test results, and reduce the risk of injury to healthcare workers handling frozen specimens. The medical thawing system meets strict regulatory standards for handling biological materials and is essential in ensuring the quality and efficacy of the thawed specimen. As a result, it is widely employed across various healthcare facilities as a reliable, efficient, and standardized device for ensuring the quality and efficacy of biological samples used in patient care and research.
Medical Thawing System Market Trends:
The rising number of individuals suffering from chronic diseases and viral and bacterial infections is one of the primary factors driving the market growth. In line with this, the growing inclination toward organ transplantation and an increase in organ donors combined with the surging demand for blood transfusions is creating a favorable outlook for the market. In addition to this, the expanding demand for regenerative medicine is fuelling the need for safe and efficient thawing of stem cells, tissues, and other biological samples, which, in turn, is contributing to the market growth. Moreover, innovative technological advancements, such as the integration of automation and robotics technology to enhance the efficiency and accuracy of thawing systems, are presenting remunerative growth opportunities for the market. Furthermore, the outbreak of the COVID-19 virus has impelled the collection of tissue specimens for researching the biological impact of the infection and identifying new therapeutic interventions and prevention strategies, which is positively impacting the market growth. Other factors, such as the rising geriatric population, increasing healthcare expenditure, growing number of people participating in blood donation campaigns, the escalating demand for personalized medicines, and extensive investments in research and development (R&D) projects to develop effective therapies for treating rare diseases, are strengthening the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical thawing system market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product type, sample type and end user.
Product Type Insights:
Manual
Automated
The report has provided a detailed breakup and analysis of the medical thawing system market based on the product type. This includes manual and automated. According to the report, the manual represented the largest segment.
Sample Type Insights:
Blood
Plasma
Stem Cells
Whole Blood
Platelets
Embryo
Ovum
Semen
A detailed breakup and analysis of the medical thawing system market based on the sample type has also been provided in the report. This includes blood (plasma, stem cells, whole blood and platelets), embryo, ovum and semen. According to the report, blood accounted for the largest market share.
End User Insights:
Blood Banks
Hospitals
Tissue Banks
Pharmaceutical and Biotech Companies
Others
The report has provided a detailed breakup and analysis of the medical thawing system market based on the end-user. This includes blood banks, hospitals, tissue banks, pharmaceutical and biotech companies, and others. According to the report, blood banks represented the largest segment.
Regional Insights:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for medical thawing system. Some of the factors driving the North America medical thawing system market included the growing prevalence of life-threatening chronic diseases, the increasing adoption of regenerative and personalized medicines, and the rising geriatric population.
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global medical thawing system market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report
1. What was the size of the global medical thawing system market in 2024?
2. What is the expected growth rate of the global medical thawing system market during 2025-2033?
3. What are the key factors driving the global medical thawing system market?
4. What has been the impact of COVID-19 on the global medical thawing system market?
5. What is the breakup of the global medical thawing system market based on the product type?
6. What is the breakup of the global medical thawing system market based on the sample type?
7. What is the breakup of the global medical thawing system market based on the end user?
8. What are the key regions in the global medical thawing system market?
9. Who are the key players/companies in the global medical thawing system market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Medical Thawing System Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Manual
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Automated
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Sample Type
7.1 Blood
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Plasma
7.1.2.2 Stem Cells
7.1.2.3 Whole Blood
7.1.2.4 Platelets
7.1.3 Market Forecast
7.2 Embryo
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Ovum
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Semen
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End User
8.1 Blood Banks
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospitals
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Tissue Banks
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Pharmaceutical and Biotech Companies
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Barkey GmbH & Co. KG
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Biolife Solutions Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Boekel Scientific
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Cardinal Health Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 General Electric Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Helmer Scientific Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Hospicare Systems
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 labcold Limited
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 MMS Medical and Laboratory Supplies
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Sarstedt AG & Co. KG
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Sartorius AG
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Terumo Penpol Private Limited (Terumo Corporation)
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Thermo Fisher Scientific Inc.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
*** 医療用融解システムの世界市場に関するよくある質問(FAQ) ***
・医療用融解システムの世界市場規模は？
→IMARC社は2024年の医療用融解システムの世界市場規模を2億1920万米ドルと推定しています。
・医療用融解システムの世界市場予測は？
→IMARC社は2033年の医療用融解システムの世界市場規模を3億9080万米ドルと予測しています。
・医療用融解システム市場の成長率は？
→IMARC社は医療用融解システムの世界市場が2025年～2033年に年平均6.3%成長すると展望しています。
・世界の医療用融解システム市場における主要プレイヤーは？
→「Barkey GmbH & Co. KG, Biolife Solutions Inc., Boekel Scientific, Cardinal Health Inc., General Electric Company, Helmer Scientific Inc., Hospicare Systems, labcold Limited, MMS Medical and Laboratory Supplies, Sarstedt AG & Co. KG, Sartorius AG, Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc.など ...」を医療用融解システム市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
